BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Barry Myers is a featured speaker at CED's MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
